Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Marts 2024

Genmab — Marts 2024

Planlagt Fastgjort Låst Flyttet Genmab
830 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • P Offline
    P Offline
    ProinvestorNEWS
    wrote on sidst redigeret af
    #641

    FDA Fully Approves AbbVie's Elahere For Ovarian Cancer https://www.proinvestor.com/investornyt/1135920/fda-fully-approves-abbvies-elahere-for-ovarian-cancer

    1 Reply Last reply
    0
    • J Offline
      J Offline
      JKY_VH
      wrote on sidst redigeret af
      #642

      Ja Helge, men derfor kan det godt blive en god uge, hvor en del udbytter skal geninvesteres og god morgen:-)

      1 Reply Last reply
      0
      • Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktør
        wrote on sidst redigeret af
        #643

        Bibob og JKY. Det satser vi på 🙂

        1 Reply Last reply
        0
        • SolsenS Offline
          SolsenS Offline
          Solsen
          wrote on sidst redigeret af
          #644

          14-18.000 aktier opkøbes daglig https://www.proinvestor.com/investornyt/1136150/transactions-in-connection-with-share-buy-back-program

          1 Reply Last reply
          0
          • K Offline
            K Offline
            Klarussen
            wrote on sidst redigeret af
            #645

            Fint, fint

            1 Reply Last reply
            0
            • MadsSkjernM Offline
              MadsSkjernM Offline
              MadsSkjern
              wrote on sidst redigeret af
              #646

              Regeneron har problemer i CD20XCD3.

              1 Reply Last reply
              0
              • MadsSkjernM Offline
                MadsSkjernM Offline
                MadsSkjern
                wrote on sidst redigeret af
                #647

                https://firstwordpharma.com/story/5839955

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #648

                  Abstract 509: The MPS1/TTK inhibitor, NMS-01940153, synergizes with tisotumab vedotin in colorectal cancer https://aacrjournals.org/cancerres/article/84/6_Supplement/509/737622/Abstract-509-The-MPS1-TTK-inhibitor-NMS-01940153?searchresult=1

                  1 Reply Last reply
                  0
                  • L Offline
                    L Offline
                    lahn1
                    wrote on sidst redigeret af
                    #649

                    Det er vist så meget sagt. Lyder til at være en fodfejl hos Regeneron, som der blive rette op. Men sjældent man ser en Priority Review få CRL, tænker jeg.

                    1 Reply Last reply
                    0
                    • M Offline
                      M Offline
                      MarsFars
                      wrote on sidst redigeret af
                      #650

                      Ser ud til at der er nogen der sælger på det stærke købssignal fra i går 😉 Så deeeet

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #651

                        Abstract 5071: Minimal residual disease (MRD) status by peripheral blood mononuclear cells (PBMCs) and circulating tumor DNA (ctDNA) demonstrates rapid, deep, and sustained response in patients (Pts) with relapsed/refractory follicular lymphoma (R/R FL) treated with subcutaneous (SC) epcoritamab monotherapy in the pivotal phase 1/2 EPCORE™ NHL-1 trial https://aacrjournals.org/cancerres/article/84/6_Supplement/5071/736959/Abstract-5071-Minimal-residual-disease-MRD-status?searchresult=1

                        1 Reply Last reply
                        0
                        • L Offline
                          L Offline
                          lahn1
                          wrote on sidst redigeret af
                          #652

                          Tak EL !

                          1 Reply Last reply
                          0
                          • SEACOPS Offline
                            SEACOPS Offline
                            SEACOP
                            wrote on sidst redigeret af
                            #653

                            Supersupport, 12 mdr., med stor tak. Ingen bog, som er god, alt til det gode formål. (link)

                            1 Reply Last reply
                            0
                            • SEACOPS Offline
                              SEACOPS Offline
                              SEACOP
                              wrote on sidst redigeret af
                              #654

                              https://www.proinvestor.com/support

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #655

                                UBS analyst Xian Deng Reiterates Buy Rating on Genmab A/S (PT 2800) https://www.streetinsider.com/Intl+Ratings/UBS+Reiterates+Buy+Rating+on+Genmab+AS+(GEN%3ADC)+(GMAB)/22976308.html

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #656

                                  and i think Sachin Jain from
                                  Bank of America Securities
                                  Reiterated Buy Yesterday (PT Kr.255.33 mistaken again, must probably be Kr 2553.3)

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    ProinvestorNEWS
                                    wrote on sidst redigeret af
                                    #657

                                    Aktier/middag: Mærsk til bunds efter broulykke i USA - Genmab og Danske topper https://www.proinvestor.com/investornyt/1136612/aktier-middag-maersk-til-bunds-efter-broulykke-i-usa-genmab-og-danske-topper

                                    1 Reply Last reply
                                    0
                                    • G Offline
                                      G Offline
                                      gentogen
                                      wrote on sidst redigeret af
                                      #658

                                      Lidt speciel kommentar fra foregående link: Genmab ligger øverst på grund af lidt nyt fra USA, hvor FDA's rådgivende komite skal mødes. Vi ved ikke, om det handler om Genmab og selskabets nye produkt, det har på vej, Hexabody CD38, men det er der bare meget, der tyder på, at det gør, siger Lars Hytting.

                                      1 Reply Last reply
                                      0
                                      • BulderB Offline
                                        BulderB Offline
                                        Bulder
                                        wrote on sidst redigeret af
                                        #659

                                        Ja, det måtte Hytting da gerne uddybe lidt, hvad det er der tyder på at fda skal snakke om hex38.

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #660

                                          -Use of Minimal Residual Disease as an Endpoint in Multiple Myeloma Clinical Trials
                                          https://www.federalregister.gov/documents/2024/03/26/2024-06314/oncologic-drugs-advisory-committee-notice-of-meeting-establishment-of-a-public-docket-request-for

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper